United States Biotechnology & Medical Research

Ocata Therapeutics Inc (OCAT)

Track

Ticker: OCAT Exchange: NMQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 10 Nov 2015
Value US$1,268,785.45 | Price 308.71 | Shares 94,394 (+3.5%)
Planned sale 10 Nov 2015
Value US$1,718,735.94 | Price 474.38 | Shares 57,461 (+2.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2015-11-10 2015-11-10 PlS Planned sale Lanza Robert

Chief Scientific Officer

Officer
94,394 +3.5%
308.71
US$1,268,785 		94,394 +3.5% 308.71 US$1,268,785
2015-11-10 2015-11-10 PlS Planned sale Lanza Robert

Chief Scientific Officer

Officer
57,461 +2.6%
474.38
US$1,718,736 		57,461 +2.6% 474.38 US$1,718,736
2014-09-11 2014-09-10 PlS Planned sale Lanza Robert

Chief Scientific Officer

Officer
67,881 +2.9%
52.84
US$776,531 		67,881 +2.9% 52.84 US$776,531
2014-09-09 2014-09-08 PlS Planned sale Lanza Robert

Chief Scientific Officer

Officer
10,000 -5.1%
10.07
US$100,700 		10,000 -5.1% 10.07 US$100,700
2014-09-04 2014-09-03 PlS Planned sale Lanza Robert

Chief Scientific Officer

Officer
10,000 -4.8%
9.00
US$90,000 		10,000 -4.8% 9.00 US$90,000
2014-09-04 2014-09-02 PlS Planned sale Lanza Robert

Chief Scientific Officer

Officer
5,000 -2.3%
9.01
US$45,050 		5,000 -2.3% 9.01 US$45,050
2014-07-07 2014-07-07 PlS Planned sale Lanza Robert

Chief Scientific Officer

Officer
745,000 -3.2%
0.08
US$59,600 		745,000 -3.2% 0.08 US$59,600
2013-04-15 2013-01-10 S Sale Rabin Gary H

CEO & CFO

Executive Director
1,000,000 -14.3%
0.08
US$79,200 		1,000,000 -14.3% 0.08 US$79,200
2012-12-18 2012-12-14 S Sale Lanza Robert

Chief Scientific Officer

Officer
43,000 -0.2%
0.06
US$2,580 		43,000 -0.2% 0.06 US$2,580
2012-12-18 2012-12-14 S Sale Lanza Robert

Chief Scientific Officer

Officer
100,000 -0.4%
0.06
US$5,940 		100,000 -0.4% 0.06 US$5,940
2012-12-18 2012-12-14 S Sale Lanza Robert

Chief Scientific Officer

Officer
150,000 -0.6%
0.06
US$8,895 		150,000 -0.6% 0.06 US$8,895
2012-12-18 2012-12-14 S Sale Lanza Robert

Chief Scientific Officer

Officer
545,490 -2.0%
0.06
US$32,184 		545,490 -2.0% 0.06 US$32,184
2012-12-18 2012-12-14 S Sale Lanza Robert

Chief Scientific Officer

Officer
40,000 -0.1%
0.06
US$2,340 		40,000 -0.1% 0.06 US$2,340
2012-12-18 2012-12-14 S Sale Lanza Robert

Chief Scientific Officer

Officer
440,000 -1.6%
0.06
US$25,520 		440,000 -1.6% 0.06 US$25,520
2012-12-18 2012-12-14 S Sale Lanza Robert

Chief Scientific Officer

Officer
20,000 -0.1%
0.06
US$1,158 		20,000 -0.1% 0.06 US$1,158
2013-04-15 2012-10-23 S Sale Rabin Gary H

CEO & CFO

Executive Director
650,000 -8.5%
0.07
US$45,565 		650,000 -8.5% 0.07 US$45,565
2013-04-15 2012-10-22 S Sale Rabin Gary H

CEO & CFO

Executive Director
350,000 -4.4%
0.07
US$25,025 		350,000 -4.4% 0.07 US$25,025
2013-04-15 2012-09-06 S Sale Rabin Gary H

CEO & CFO

Executive Director
391,444 -4.7%
0.08
US$32,098 		391,444 -4.7% 0.08 US$32,098
2013-04-15 2012-09-05 S Sale Rabin Gary H

CEO & CFO

Executive Director
608,556 -6.8%
0.08
US$50,023 		608,556 -6.8% 0.08 US$50,023
2013-04-15 2012-08-27 S Sale Rabin Gary H

CEO & CFO

Executive Director
1,000,000 -10.0%
0.08
US$78,400 		1,000,000 -10.0% 0.08 US$78,400
2012-08-01 2012-07-31 S Sale Lanza Robert

Chief Scientific Officer

Officer
500,000 -1.8%
0.08
US$40,000 		500,000 -1.8% 0.08 US$40,000
2012-08-01 2012-07-30 S Sale Lanza Robert

Chief Scientific Officer

Officer
190,000 -0.7%
0.08
US$15,580 		190,000 -0.7% 0.08 US$15,580
2012-08-01 2012-07-30 S Sale Lanza Robert

Chief Scientific Officer

Officer
546,793 -2.0%
0.08
US$44,290 		546,793 -2.0% 0.08 US$44,290
2012-08-01 2012-07-30 S Sale Lanza Robert

Chief Scientific Officer

Officer
151,500 -0.5%
0.08
US$12,135 		151,500 -0.5% 0.08 US$12,135
2012-08-01 2012-07-30 S Sale Lanza Robert

Chief Scientific Officer

Officer
611,707 -2.1%
0.08
US$48,937 		611,707 -2.1% 0.08 US$48,937
2013-04-15 2012-06-15 S Sale Rabin Gary H

CEO & CFO

Executive Director
350,000 -3.4%
0.07
US$25,375 		350,000 -3.4% 0.07 US$25,375
2012-06-19 2012-06-14 S Sale Rabin Gary H

CEO & CFO

Executive Director
350,000 -2.4%
0.07
US$25,095 		350,000 -2.4% 0.07 US$25,095
2012-06-19 2012-06-13 S Sale Rabin Gary H

CEO & CFO

Executive Director
300,000 -2.0%
0.07
US$21,240 		300,000 -2.0% 0.07 US$21,240
2012-06-19 2012-06-11 S Sale Rabin Gary H

CEO & CFO

Executive Director
175,029 -1.2%
0.08
US$13,127 		175,029 -1.2% 0.08 US$13,127
2013-04-15 2012-05-29 S Sale Rabin Gary H

CEO & CFO

Executive Director
24,500 -0.2%
0.08
US$1,960 		24,500 -0.2% 0.08 US$1,960
2013-04-15 2012-05-25 S Sale Rabin Gary H

CEO & CFO

Executive Director
80,000 -0.8%
0.08
US$6,440 		80,000 -0.8% 0.08 US$6,440
2013-04-15 2012-05-24 S Sale Rabin Gary H

CEO & CFO

Executive Director
95,471 -0.9%
0.08
US$7,666 		95,471 -0.9% 0.08 US$7,666
2013-04-15 2012-05-14 S Sale Rabin Gary H

CEO & CFO

Executive Director
388,090 -3.5%
0.07
US$26,584 		388,090 -3.5% 0.07 US$26,584
2013-04-15 2012-05-11 S Sale Rabin Gary H

CEO & CFO

Executive Director
290,000 -2.6%
0.07
US$20,793 		290,000 -2.6% 0.07 US$20,793
2013-04-15 2012-05-07 S Sale Rabin Gary H

CEO & CFO

Executive Director
122,000 -1.1%
0.08
US$9,821 		122,000 -1.1% 0.08 US$9,821
2013-04-15 2012-05-03 S Sale Rabin Gary H

CEO & CFO

Executive Director
199,910 -1.7%
0.08
US$16,653 		199,910 -1.7% 0.08 US$16,653
2012-01-25 2012-01-24 S Sale Lanza Robert

Chief Scientific Officer

Officer
6,658,300 -20.4%
0.19
US$1,277,728 		6,658,300 -20.4% 0.19 US$1,277,728
2013-04-15 2012-01-23 S Sale Rabin Gary H

CEO & CFO

Executive Director
625,000 -5.1%
0.18
US$109,500 		625,000 -5.1% 0.18 US$109,500
2012-01-25 2012-01-23 S Sale Lanza Robert

Chief Scientific Officer

Officer
1,000,000 -3.0%
0.18
US$175,400 		1,000,000 -3.0% 0.18 US$175,400
2013-04-15 2011-10-14 S Sale Rabin Gary H

CEO & CFO

Executive Director
720,920 -5.6%
0.14
US$104,389 		720,920 -5.6% 0.14 US$104,389
2013-04-15 2011-10-13 S Sale Rabin Gary H

CEO & CFO

Executive Director
787,429 -5.8%
0.14
US$111,657 		787,429 -5.8% 0.14 US$111,657
2013-04-15 2011-10-12 S Sale Rabin Gary H

CEO & CFO

Executive Director
491,650 -3.5%
0.15
US$71,388 		491,650 -3.5% 0.15 US$71,388
2011-09-30 2011-09-29 S Sale Lanza Robert

Chief Scientific Officer

Officer
608,225 -1.8%
0.15
US$93,058 		608,225 -1.8% 0.15 US$93,058
2011-09-30 2011-09-28 S Sale Lanza Robert

Chief Scientific Officer

Officer
108,080 -0.3%
0.15
US$16,320 		108,080 -0.3% 0.15 US$16,320
2011-09-30 2011-09-28 S Sale Lanza Robert

Chief Scientific Officer

Officer
10,000 -0.0%
0.15
US$1,520 		10,000 -0.0% 0.15 US$1,520
2013-04-15 2011-08-12 S Sale Rabin Gary H

CEO & CFO

Executive Director
539,987 -3.7%
0.17
US$91,690 		539,987 -3.7% 0.17 US$91,690
2013-04-15 2011-08-11 S Sale Rabin Gary H

CEO & CFO

Executive Director
707,913 -4.6%
0.16
US$115,956 		707,913 -4.6% 0.16 US$115,956
2013-04-15 2011-08-10 S Sale Rabin Gary H

CEO & CFO

Executive Director
135,100 -0.9%
0.16
US$21,940 		135,100 -0.9% 0.16 US$21,940
2013-04-15 2011-08-09 S Sale Rabin Gary H

CEO & CFO

Executive Director
667,000 -4.1%
0.17
US$110,322 		667,000 -4.1% 0.17 US$110,322
2011-06-03 2011-05-20 S Sale Rabin Gary H

CEO & CFO

Executive Director
750,000 -12.8%
0.20
US$150,525 		750,000 -12.8% 0.20 US$150,525
2013-04-15 2011-05-04 S Sale Rabin Gary H

CEO & CFO

Executive Director
266,898 -1.6%
0.19
US$51,938 		266,898 -1.6% 0.19 US$51,938
2013-04-15 2011-04-26 S Sale Rabin Gary H

CEO & CFO

Executive Director
733,102 -4.3%
0.18
US$130,126 		733,102 -4.3% 0.18 US$130,126
2011-05-25 2011-03-17 S Sale Rabin Gary H

CEO & CFO

Executive Director
4,000 -0.1%
0.16
US$628 		4,000 -0.1% 0.16 US$628
2011-05-25 2011-03-15 S Sale Rabin Gary H

CEO & CFO

Executive Director
781,755 -11.8%
0.16
US$128,208 		781,755 -11.8% 0.16 US$128,208
2011-05-25 2011-03-15 S Sale Rabin Gary H

CEO & CFO

Executive Director
414,245 -5.9%
0.16
US$64,208 		414,245 -5.9% 0.16 US$64,208
2011-03-08 2011-03-07 S Sale Ruoslahti Erkki Non-Executive Director
100,000 -3.5%
0.17
US$16,600 		100,000 -3.5% 0.17 US$16,600
2011-03-08 2011-03-07 S Sale Ruoslahti Erkki Non-Executive Director
150,000 -5.0%
0.17
US$25,050 		150,000 -5.0% 0.17 US$25,050
2011-03-08 2011-03-04 S Sale Ruoslahti Erkki Non-Executive Director
250,000 -7.7%
0.17
US$41,650 		250,000 -7.7% 0.17 US$41,650
2011-03-07 2011-03-03 S Sale Ruoslahti Erkki Non-Executive Director
250,000 -7.2%
0.17
US$42,500 		250,000 -7.2% 0.17 US$42,500
2011-03-03 2011-03-01 S Sale Ruoslahti Erkki Non-Executive Director
10,630 -0.3%
0.18
US$1,866 		10,630 -0.3% 0.18 US$1,866
2013-04-15 2011-02-28 S Sale Rabin Gary H

CEO & CFO

Executive Director
390,993 -2.2%
0.17
US$68,072 		390,993 -2.2% 0.17 US$68,072
2011-03-01 2011-02-28 S Sale Ruoslahti Erkki Non-Executive Director
250,000 -6.7%
0.18
US$43,750 		250,000 -6.7% 0.18 US$43,750
2011-03-01 2011-02-25 S Sale Ruoslahti Erkki Non-Executive Director
72,050 -1.9%
0.18
US$12,609 		72,050 -1.9% 0.18 US$12,609
2011-03-01 2011-02-18 S Sale Ruoslahti Erkki Non-Executive Director
250,000 -6.1%
0.18
US$43,750 		250,000 -6.1% 0.18 US$43,750
2011-03-01 2011-02-17 S Sale Ruoslahti Erkki Non-Executive Director
107,675 -2.6%
0.18
US$18,843 		107,675 -2.6% 0.18 US$18,843
2011-03-01 2011-02-17 S Sale Ruoslahti Erkki Non-Executive Director
10,000 -0.2%
0.18
US$1,760 		10,000 -0.2% 0.18 US$1,760
2011-03-01 2011-02-17 S Sale Ruoslahti Erkki Non-Executive Director
5,000 -0.1%
0.18
US$875 		5,000 -0.1% 0.18 US$875
2011-03-01 2011-02-17 S Sale Ruoslahti Erkki Non-Executive Director
10,000 -0.2%
0.18
US$1,769 		10,000 -0.2% 0.18 US$1,769
2011-03-01 2011-02-17 S Sale Ruoslahti Erkki Non-Executive Director
2,876 -0.1%
0.18
US$503 		2,876 -0.1% 0.18 US$503
2011-02-18 2011-02-14 S Sale Ruoslahti Erkki Non-Executive Director
150,000 -3.4%
0.19
US$28,035 		150,000 -3.4% 0.19 US$28,035
2011-02-18 2011-02-14 S Sale Ruoslahti Erkki Non-Executive Director
250,000 -5.4%
0.19
US$46,325 		250,000 -5.4% 0.19 US$46,325
2011-02-15 2011-02-11 S Sale Ruoslahti Erkki Non-Executive Director
137,650 -2.9%
0.18
US$25,190 		137,650 -2.9% 0.18 US$25,190
2011-02-15 2011-02-10 S Sale Ruoslahti Erkki Non-Executive Director
173,100 -3.5%
0.19
US$32,024 		173,100 -3.5% 0.19 US$32,024
2011-02-15 2011-02-10 S Sale Ruoslahti Erkki Non-Executive Director
66,900 -1.3%
0.19
US$12,443 		66,900 -1.3% 0.19 US$12,443
2011-02-15 2011-02-10 S Sale Ruoslahti Erkki Non-Executive Director
10,000 -0.2%
0.19
US$1,866 		10,000 -0.2% 0.19 US$1,866
Explore more

More insider trading research around Ocata Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America